Pharmacophore class

Scheme 6.1 Chemical structures of adrenergic receptor antagonists for generation of antitarget pharmacophores class I (a) and class II (b).

Inhibitors could target the substrate binding pocket. This voluminous pocket can accommodate an extraordinary variety of structures hence, many distinct pharmacophore classes can be foreseen. Importantly, the binding site ofthe RND transporter is located in the periplasm, so that an inhibitor need only cross one membrane. 

This rarity value is equated with the fraction of hits that would be returned by searching large database of diverse molecules with the full pharmacophore (all K features) or thi subset (with K—1 features) as appropriate. Labelling this fraction of hits as p(x) we nov define q x) as the fraction of the M active molecules (i.e. the molecules originally suppliet as input to the procedure) which match each of the K + possible classes. The overal configuration is scored using ... 

There ate many classes of anticonvulsant agent in use, many associated with side effect HabiUties of unknown etiology. Despite many years of clinical use, the mechanism of action of many anticonvulsant dmgs, with the exception of the BZs, remains unclear and may reflect multiple effects on different systems, the summation of which results in the anticonvulsant activity. The pharmacophore stmctures involved are diverse and as of this writing there is htde evidence for a common mechanism of action. Some consensus is evolving, however, in regard to effects on sodium and potassium channels (16) to reduce CNS excitation owing to convulsive episodes. 

The most widely used variant of the Gabriel-Colman is the conversion of saccharine derivatives to benzothiazine derivatives. The reaction has been extensively studied as benzothiazines are important pharmacophores, particularly in the oxicam class of antiinflammatories. The first reported instance of this transformation was in 1956 where 43 was treated with sodium methoxide to provide 44. The rearrangement also works with esters " and some amides " in addition to ketones. 

Zhang J, Yu K, Zhu W, Jiang H (2006) Neuraminidase pharmacophore model derived from diverse classes of inhibitors. Bioorg Med Chem Lett 16 3009-3014 Ziircher T, Yates PJ, Daly J, Sahasrabudhe A, Walters M, Dash L, Tisdale M, McKimm-Breschkin JL (2006) Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother 58 723-732... 

NMR 3D structure of the undecapeptide U-II generated a ligand pharmacophore hypothesis that served as query for the virtual screening of the Aventis in-house compound repository. Active leads from six different chemical classes could be identihed by the 3D search, for example, compound 17 (ECso = 400nM Fig. 16.2) [91]. 

Dayam R, Sanchez T, Clement O, Shoemaker R, Sei S, Neamati N. P-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. J Med Chem 2005 48 111-20. 

Medicinal chemists have a distinct advantage in pursuing mechanism-of-action studies because it is possible to synthesize a series of structurally related congeners and measure their biological activity. A correlation between activity and particular structural features not only helps to identify the pharmacophore, or active moiety imbedded within the molecule, but also may establish critical requirements or complementarity for the biological target or receptor for the particular drug class. 

By experiments performed as discussed here, the reversible inhibition modality of each lead compound, representing a distinct pharmacophore or chemical structural class, can be defined and the dissociation constant (A) or aK<) can be determined from the data fitting to Equations (3.1) through (3.6). As lead analogues are produced within a structural series, one can generally assume that the inhibiton modality will be the same as that of the founder molecule (i.e., the lead) of that structural series. This assumption simplifies the determination of dissociation constants for other series molecules, as described below. However, this assumption must be... 

A novel class of cathepsin B inhibitors has been developed with a 1,2,4-thiadiazole heterocycle as the thiol-trapping pharmacophore. The most potent inhibitor is compound 128 <2003BML5529>. 

Figure 6.3 Common-feature pharmacophores ofala adrenergic receptor antagonists [16]. Onto each pharmacophore the reference has been mapped, (a) Class I pharmacophore model aligned to prazosin, (b) class II pharmacophore model aligned to compound 10.

Figure 6.4 Enrichment graph for virtual pharmacophore magenta class II...

---